Key Operational Highlights Q1'FY22 slide image

Key Operational Highlights Q1'FY22

PI's value proposition Pi Inspired by Science Favorable dynamics driving Indian chemical industry growth 1 • Global specialty chemicals market expected to grow at 5.4% CAGR¹ • Increasing focus on CSM as innovators shift focus to core competencies, developing new active ingredients and outsource production • M&A activities boosting specialized CSM players Emerging new areas of innovation such as batteries, coatings, etc. • Global supply chain risk diversification: China facing issues - pollution, trade wars, safety issues Business model ready to go beyond Ag-Chem 2 • Business built on end-to- end partnerships with global innovators •~90% CSM revenues from patented molecules; 60%+ domestic revenues from in-licensed molecules • Proven capabilities in agrochemicals; now ready to be replicated across other chemicals segments ⚫FY22 started with entry into pharma via strategic acquisition of API & intermediates business undertaking of Ind-Swift Laboratories Offerings across the value chain driven by strategic partnership 3 • Integrated and innovative services to provide • Comprehensive solutions by partnerships Relationships with 20+ • global innovators built on IP protection Strong tangibles: R&D, manufacturing, extensive network of intangibles: Brands • 4 Globally certified with use of Technology, 4 manufacturing facilities, 15 production blocks • 5 formulation facilities • R&D team of ~350 researchers and scientists • Technology enabled distribution network and relationships with more than 2.5 million farmers/retailers Quality governance, talent & learning skills 5 Professionals with expertise across various technical and business functions • Senior management team of qualified experienced professionals Performance over a long term period 6 • Revenue CAGR (FY18- FY21) of 25.6%2 ⚫ EBITDA CAGR (FY18-FY21) of 27.2%3 • Pre-tax RoCE of more than 20% over last 4 years4 Well positioned to capture value from changing market landscape Note: (1) FY19-24 CAGR;Source: Frost & Sullivan; (2) Revenue = Revenue from operating - excise duty; (3) EBITDA = Revenue - Cost of Materials consumed - Purchase of Stock in Trade - Changes in Inventories of FG,WIP and stock in trade - Employee Benefits expense - Other Expenses; (4) Pre-tax ROCE %=(EBITDA-D&A)/ Average Capital Employed (CE); CE=Net Debt + Total Equity. 14
View entire presentation